✅ Medically Reviewed by Dr. Tom Biernacki, DPM
Board-certified podiatric physician & surgeon | Balance Foot & Ankle | Updated April 2026
⚡ Quick Answer: How do you treat erythromelalgia of the foot?
Erythromelalgia is managed with cooling measures, aspirin, nerve-modulating medications, and lifestyle modifications. A multidisciplinary approach with podiatric and neurologic care produces the best outcomes.
Erythromelalgia treatment depends on whether it is primary (idiopathic) or secondary (caused by another condition). Immediate relief comes from cooling (cold water soaks, elevation, fans), and avoiding heat and pressure. Medical management includes aspirin (effective in polycythemia vera-associated cases), sodium channel blockers (mexiletine, lidocaine), and low-dose naltrexone. Secondary erythromelalgia requires treating the underlying condition — myeloproliferative disorders must be ruled out at diagnosis.
The burning starts in your feet — a searing, relentless heat that can be triggered by walking, warm rooms, or even the weight of a bed sheet. Erythromelalgia is one of the most misunderstood and underdiagnosed conditions we see in podiatric practice. Patients often wait years for a correct diagnosis, trying everything from antifungal creams to multiple pair of shoes, not realizing the problem originates in the small blood vessels of the foot rather than the skin or musculoskeletal system. In our clinic, understanding this condition — and ruling out serious secondary causes — is the critical first step to effective management.
What Is Erythromelalgia
Erythromelalgia (also spelled erythermalgia) is a rare neurovascular condition characterized by episodic attacks of intense burning pain, visible redness (erythema), and warmth in the extremities — most commonly the feet, less commonly the hands. The name derives from the Greek: erythros (red), melos (limb), and algos (pain). The fundamental pathology involves abnormal dilation of small arterioles in the skin, causing excessive blood pooling and resulting in the characteristic triad of burning pain, redness, and heat.
The condition is relatively rare — affecting approximately 1–2 per 100,000 people — but is likely underdiagnosed due to its episodic nature and the tendency for symptoms to fluctuate. It can present at any age, with two peaks: childhood/young adulthood (often primary) and middle age (often secondary to another condition). As podiatrists, we’re frequently the first specialists these patients see, because the feet are the most common site and patients naturally seek foot care first.
Symptoms and Episode Pattern
The classic presentation is episodic attacks of burning pain, redness, and warmth in both feet that are triggered by warmth and exercise and dramatically relieved by cooling. Between episodes, feet may appear completely normal, which contributes to diagnostic confusion. Episodes can last minutes to hours and may occur multiple times daily in severe cases.
Key symptoms include: intense burning or stinging pain in the feet (described as “walking on hot coals”), visible redness and mottled skin during episodes, skin that is warm or hot to touch during attacks, relief from cooling — cold water soaks, walking barefoot on cold floors, using fans, aggravation by warmth, exercise, prolonged standing, tight shoes, or alcohol, and in severe cases, constant pain with no pain-free intervals. Some patients develop skin changes over time from repeated ischemia-reperfusion cycles, including subtle discoloration or textural changes.
Primary vs Secondary Erythromelalgia
Distinguishing primary from secondary erythromelalgia is the most important early step because secondary causes — particularly blood disorders — require urgent specialist referral. This is not a distinction to skip or defer. In our practice, any new diagnosis of erythromelalgia triggers an immediate complete blood count (CBC) and referral to hematology if abnormal.
| Type | Cause | Age of Onset | Key Treatment |
|---|---|---|---|
| Primary (Idiopathic) | SCN9A gene mutation (Nav1.7 sodium channel) or unknown | Childhood to young adulthood; family history common | Sodium channel blockers, low-dose naltrexone, cooling |
| Secondary — Myeloproliferative | Polycythemia vera, essential thrombocythemia (JAK2 mutation) | Middle-to-older age, platelet count elevated | Aspirin 500mg daily — often dramatically effective |
| Secondary — Autoimmune | Lupus, RA, MCTD | Variable | Treat underlying condition; hydroxychloroquine |
| Secondary — Neuropathic | Small fiber neuropathy, diabetes | Variable, often middle age | Neuropathic pain agents (gabapentin, duloxetine) |
| Drug-Induced | Calcium channel blockers (nifedipine, amlodipine), bromocriptine | After starting medication | Discontinue offending agent with prescriber guidance |
Causes and Triggers
The underlying mechanism of erythromelalgia involves pathological small arteriole dilation combined with arteriovenous shunting — blood bypasses the capillary beds and pools in the skin, causing the characteristic heat and redness. In primary erythromelalgia with SCN9A mutations, voltage-gated sodium channels in nociceptors become hypersensitive to warmth, producing spontaneous firing and the burning pain sensation.
Common episode triggers include: ambient warmth or hot weather, prolonged standing or walking, exercise, warm water (baths, showers), tight socks or shoes, eating spicy foods, alcohol consumption, emotional stress, and lying in bed with feet covered. Understanding and avoiding your personal trigger pattern is the first step in lifestyle management — we ask every patient to keep a trigger diary during the initial treatment phase.
Diagnosis and Workup
Erythromelalgia is a clinical diagnosis — there is no single definitive test. The diagnosis is made by the characteristic history of episodic heat, redness, and burning pain in the feet that is relieved by cooling and triggered by warmth or exercise. However, the workup to identify secondary causes is mandatory and should never be skipped.
Essential workup includes: complete blood count with differential (elevated platelets or red cell mass suggests myeloproliferative disease), comprehensive metabolic panel, fasting glucose and HbA1c (screen for diabetes), ESR and ANA (autoimmune screen), and skin biopsy for small fiber nerve density if neuropathy is suspected. Thermography can objectively document temperature differences during episodes. Genetic testing for SCN9A mutation is available for familial cases but rarely changes initial management. The differential diagnosis includes peripheral neuropathy (burning but no redness/warming during episodes), Raynaud’s phenomenon (vasoconstriction causing white/blue color — opposite of erythromelalgia), complex regional pain syndrome, and cellulitis.
Treatment Options for Erythromelalgia
There is no universally effective treatment for erythromelalgia, and management must be individualized based on type (primary vs secondary), severity, and response to initial measures. The treatment hierarchy proceeds from conservative cooling and lifestyle modification through topical agents, oral medications, regional nerve blocks, and experimental therapies. Most patients require combination approaches, and realistic expectations are important — complete elimination of symptoms is uncommon, but significant reduction in episode frequency and severity is achievable for most patients.
Cooling and Lifestyle Management
Cooling is the most immediate and universally effective intervention during an erythromelalgia episode. However, it carries a critical caveat: prolonged immersion in ice-cold water causes skin damage and, paradoxically, can worsen the condition over time through ischemia-reperfusion injury. We counsel patients to use cool (not ice cold) water for no more than 15–20 minutes per episode, and never to immerse feet in ice water. A fan blowing over the feet is safer and often sufficient for mild episodes.
Environmental and lifestyle modifications include: keeping bedroom temperature cool (65–68°F), using lightweight breathable sheets (no heavy duvets), wearing open-toed sandals or mesh shoes, avoiding synthetic socks and tight footwear, adjusting work environment temperature where possible, avoiding known dietary triggers (alcohol, spicy foods), and scheduling exercise during the coolest part of the day. While these measures don’t treat the underlying condition, they dramatically reduce episode frequency for most patients and are the foundation of the management plan.
Medications for Erythromelalgia
Medication selection is guided by the erythromelalgia type and underlying cause. The following are the most evidence-supported options — all should be managed in coordination with your physician or specialist team, particularly when secondary causes are present.
Aspirin (500mg–1g daily): The single most effective medication for secondary erythromelalgia associated with polycythemia vera or essential thrombocythemia. A single dose can abort an episode within hours. Virtually ineffective in primary erythromelalgia — which is why establishing type first is critical. Sodium channel blockers: For primary (Nav1.7 mutation) erythromelalgia, mexiletine (oral sodium channel blocker) and IV lidocaine infusions have shown benefit in case series. Carbamazepine and lacosamide are also used. These are second-line options requiring neurological or pain specialist management. Low-dose naltrexone (LDN, 1.5–4.5mg nightly): Growing evidence in chronic pain conditions including erythromelalgia. Anti-inflammatory via glial modulation. Well-tolerated and inexpensive. A reasonable trial in refractory cases. Serotonin-norepinephrine reuptake inhibitors (venlafaxine, duloxetine): Particularly useful when neuropathy or small fiber dysfunction is the underlying mechanism. Topical agents: Compounded topical lidocaine, capsaicin (desensitizes TRPV1 channels with repeated application), and ketamine/amitriptyline creams are used by some specialists. They reduce systemic side effects and can be applied during episodes. Sympathetic nerve blocks and spinal cord stimulation: For severe, refractory cases, regional sympathetic nerve blocks (lumbar sympathetic chain) and spinal cord stimulation have produced sustained relief in case reports and small series. These are tertiary-level interventions.
- New-onset erythromelalgia in any patient over age 40 — rule out myeloproliferative disease (polycythemia vera, essential thrombocythemia) with CBC immediately
- Elevated platelet count (>400,000) or elevated hematocrit on routine labs
- Episodes increasingly frequent and severe despite conservative management
- Skin breakdown, ulceration, or wounds over erythematous areas
- Unilateral erythromelalgia (asymmetric) — suggests structural or vascular pathology rather than systemic cause
- Associated constitutional symptoms: weight loss, fatigue, night sweats (myeloproliferative red flags)
The Most Common Mistake with Erythromelalgia
The most dangerous mistake is failing to rule out secondary causes — particularly myeloproliferative disorders — before attributing erythromelalgia to primary idiopathic disease. Polycythemia vera and essential thrombocythemia are blood cancers that require prompt hematological management; a missed diagnosis because “the feet just burn” can have serious consequences. The second major mistake we see is compulsive ice-water immersion — patients find immediate relief from ice-cold soaks, but prolonged use causes skin maceration, ischemia, and secondary ulceration. We see patients who have damaged their skin severely from daily ice baths. Cool running water for 15 minutes maximum is the appropriate protocol.
Recommended Products for Erythromelalgia Management
For erythromelalgia patients who experience persistent burning between acute episodes, Doctor Hoy’s Natural Pain Relief Gel provides topical arnica and camphor-based anti-inflammatory action. Apply to the foot during early episodes or between acute attacks to reduce baseline inflammation. Unlike ice water, topical gel does not risk skin damage from prolonged cold exposure.
Ideal for: Between-episode burning, mild-to-moderate daily pain management, patients avoiding systemic NSAIDs
Not ideal for: Active episodes requiring immediate cooling, open skin, allergy to arnica or camphor
For erythromelalgia patients who cannot tolerate any sock material against their feet due to heat sensitivity, FLAT SOCKS thin no-show shoe inserts absorb moisture and provide a minimal barrier without the heat-trapping effect of traditional socks. Allows barefoot-style comfort inside shoes.
Ideal for: Patients who cannot wear socks due to heat sensitivity, open shoe wear, warm weather management
Not ideal for: Athletic use requiring full sock protection, patients with skin breakdown
Evaluation at Balance Foot & Ankle
Erythromelalgia requires a systematic workup to rule out serious secondary causes before treatment. Dr. Tom Biernacki will perform a thorough evaluation, order appropriate labs, and coordinate with your primary care or hematology team to ensure the diagnosis is complete before initiating management.
Same-day appointments available · Howell & Bloomfield Hills, MI
Book Your Evaluation →Frequently Asked Questions About Erythromelalgia
What triggers an erythromelalgia flare?
Common triggers include warmth (warm rooms, hot weather, warm baths), prolonged standing or walking, exercise, tight shoes or socks, alcohol, spicy foods, and emotional stress. Most patients have a personalized trigger pattern — keeping a diary during the first weeks of management helps identify and avoid your specific triggers.
Is erythromelalgia a lifelong condition?
Primary erythromelalgia (especially with SCN9A mutation) is typically lifelong but can be managed effectively. Secondary erythromelalgia may resolve if the underlying condition is treated — for example, erythromelalgia associated with polycythemia vera often improves significantly with cytoreductive therapy. Drug-induced cases resolve when the offending medication is stopped.
Is aspirin helpful for erythromelalgia?
Aspirin is highly effective specifically for erythromelalgia secondary to myeloproliferative disorders (polycythemia vera, essential thrombocythemia). A 500mg dose can abort an episode within hours in these patients. Aspirin is typically not effective for primary (idiopathic) erythromelalgia. This is one reason establishing the type is critical before starting treatment.
When should I see a podiatrist for burning foot pain?
See a podiatrist if you have episodic burning, redness, and warmth in your feet triggered by heat or exercise and relieved by cooling. Any new-onset burning foot symptoms warrant evaluation to rule out peripheral neuropathy, vascular disease, or secondary causes. Early diagnosis of erythromelalgia — particularly ruling out myeloproliferative disease — is important for appropriate management.
Does insurance cover erythromelalgia treatment?
Office visits, diagnostic lab work, and X-rays are covered by most insurances. Genetic testing is covered variably. Compounded topical medications may require prior authorization. Spinal cord stimulation for severe refractory cases is covered by most major insurers when conservative treatment has failed and criteria are met. Our team will verify your coverage before treatment.
Sources
1. Davis MDP, Sandroni P, Rooke TW, Low PA. Erythromelalgia: vasculopathy, neuropathy, or both? A prospective study of vascular and neurophysiologic studies in erythromelalgia. Arch Dermatol. 2003;139(10):1337–1343.
2. Yang Y, Wang Y, Li S, et al. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet. 2004;41(3):171–174.
3. Mork C, Asker CL, Salerud EG, Kvernebo K. Microvascular arteriovenous shunting is a probable pathogenetic mechanism in erythromelalgia. J Invest Dermatol. 2000;114(4):643–646.
4. Drenth JP, Michiels JJ. Erythromelalgia and erythermalgia: diagnostic differentiation. Int J Dermatol. 1994;33(6):393–397.
5. Cohen JS. Erythromelalgia: new theories and new therapies. J Am Acad Dermatol. 2000;43(5 Pt 1):841–847.
Related Conditions & Resources
For more on related conditions and treatments:
- Burning feet syndrome (Grierson-Gopalan)
- Peripheral neuropathy in feet
- Diabetic foot pain causes
- Gout in the foot: symptoms & treatment
- Best supplements for neuropathy
- Howell podiatrist office
- Bloomfield Hills podiatrist office
Need to see a podiatrist? Call (810) 206-1402 or book online. Same-week availability.
Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.
- Diagnosis and Treatment of Plantar Fasciitis (PubMed / AAFP)
- Heel Pain (APMA)
- Hallux Valgus (Bunions): Evaluation and Management (PubMed)
- Bunions (Mayo Clinic)